BONDRONAT ibandronic acid 50 mg film-coated tablet blister pack, Atnahs Pharma Australia Pty, CON-1085
Product name
BONDRONAT ibandronic acid 50 mg film-coated tablet blister pack
Sponsor name
Atnahs Pharma Australia Pty
Batches
P0005B08W01, P0025B01W02, P0025B01W03 and P0025B01W04
Consent start
Consent no.
CON-1085
Duration
The consent is effective from 20 March 2023 until the stated batch/es are exhausted or 30 November 2024.
Standard
paragraphs 8(1)(f) and 8(1)(g) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines
Non-compliance with standard
The product label does not have the batch number and expiry date prefixes
included in the debossing of the blister foil.
Therapeutic product type
Prescription medicines